Endobronchial ultrasound biopsy market

Endobronchial ultrasound is a technique that helps to visualize the structure around the tracheobronchial tree. Endobronchial ultrasound helps to identify the disease that can affect respiratory system such as chronic pulmonary obstructive disorder and tuberculosis, resulting in enlarged lymph and tumor in the chest. Moreover, for diagnosis and staging of lung cancer, bronchoscopy play an important role in direct visualization of the disease.

EBUS bronchoscopy uses a flexible thin tube, which is passed through the patient’s mouth or nose, and further downward into throat and at lastly into the lungs. If lung cancer is suspected, sample of the tissue is collected for analysis of the disease. Furthermore, there are two types of endobronchial ultrasounds such as radial probe endobronchial probe (RP-EBUS) and convex probe end bronchial probe (CP-EBUS). The advantages offered by the endobronchial ultrasound include that patient recover quickly, as it is less invasive.

Global Endobronchial Ultrasound Biopsy Market Drivers

The global endobronchial ultrasound biopsy market is expected to witness significant growth over forecast period, owing to increasing prevalence of lung cancer among people globally. For instance, according to World Health Organization (WHO), around 2.09 million people suffered from lung cancer, while 1.76 million deaths were reported due to lung cancer, in 2018, globally.

Furthermore, according to the Cancer Research UK, lung cancer is the third most common cancer in the U.K. and accounted for 13% new cancer cases in 2017. In addition, according to the same source, in 2017, 25,000 new cases of lung cancer were reported in men, while 22,300 new cases of lung cancer in women. From the same source, incidence rate of lung cancer in the U.K. was highest in people aged 85 to 89 years, from 2015 to 2017.

Global Endobronchial Ultrasound Biopsy Market Restraints

However, complication related to sedation such as hypoxemia and hypotension that can occur during performing bronchoscopy procedures is one of the major restraints that is expected to hamper the global endobronchial ultrasound biopsy market growth.

Moreover, in lung cancer, endobronchial ultrasound is unable to stage entire mediastinum, and it is limited to anterosuperior mediastinum. Moreover, in some anatomic location such as upper lobes, endobronchial ultrasound is difficult to perform. Therefore, these factors are expected to hamper the global endobronchial ultrasound biopsy market growth over the forecast period.

Global Endobronchial Ultrasound Biopsy Market Regional Analysis

North America is expected to account for highest market share in global endobronchial ultrasound biopsy market, owing to increasing prevalence of lung cancer among people in the region. For instance, according to the American Cancer Society’s (ACS) 2019 report, in the U.S, around 228,820 new cases of lung cancer is expected to occur in 2020. Moreover, according to the same source, in 2020, in U.S 116,300 new cases of lung cancer are expected to occur in men, while 112,520 new cases of lung cancer in women. Furthermore, according to the same source, most of the people diagnosed with lung cancer are 65 or older age. The average rate of people diagnosed with lung cancer is aged 70.

Asia Pacific is expected to exhibit highest CAGR in the forecast period due to growing incidence of lung cancer disease among people in this region. For instance, according to the International Agency for Research on Cancer (IARC), in 2018, around 1.8 million people were reported to die due to cancer globally, of which 61.4 % deaths were reported in the Asia Pacific region.

Global Endobronchial Ultrasound Biopsy Market Key Players

Key players operating in the global endobronchial ultrasound biopsy market include Boston Scientific Corporation, Medtronic PLC, Olympus Corporation, Cook Medical Incorporated, Veran Medical Technologies, Medi-Globe Corporation, Pentax Medical, FUJIFILM Corporation, and Simbionix USA Corporation.

Market Taxonomy:

On the basis of type, the global endobronchial ultrasound biopsy market is segmented into:

• Radial Probe Endobronchial Ultrasound
• Convex Probe Endobronchial Ultrasound

On the basis of application, the global endobronchial ultrasound biopsy market is segmented into:

• Lung Cancer
• Lung Infection
• Chronic Pulmonary Obstructive Disorder
• Others

 On the basis of end user, the global endobronchial ultrasound biopsy market is segmented into:

• Hospital
• Cancer Specialty Clinics
• Ambulatory Surgical Centers
• Others

On the basis of region, the global endobronchial ultrasound biopsy market is segmented into:

• North America
• Latin America
• Europe
• Middle East
• Asia Pacific
• Africa